322
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Informed Consent Process in Alpha-1 Testing of At-Risk Children: Views of Parents and Adults Tested as Children

, &
Pages 30-38 | Published online: 08 Feb 2011

REFERENCES

  • Strange C, Moseley MA, Jones Y, Schwarz L, Xie L, Brantly ML. Genetic testing of minors for alpha1-antitrypsin deficiency. Arch Ped Adol Med 2006; 160(5):531–534.
  • Wencker M, Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 2001; 119(3):737–744.
  • Alpha1-Antitrypsin Registry Study Group, Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin: the Alpha1-Antitrypsin Registry Study Group. Amer J Respir Crit Care Med, 1998; 158:49–59.
  • Sevick MA, Nativio DG, McConnell T. Genetic testing of children for late onset disease. Camb Quart Health Ethics 2005: 14:47–56.
  • Bradbury AR, Patrick-Miller L, Egleston B, Sands CB, Li T, Schmidheiser H, Feigon M, Ibe CN, Hlubocky FJ, Hope K, Jackson S, Corbman M, Olopade IO, Daly M, Daugherty CK. Parent opinions regarding the genetic testing of minors for BRCA1/2. J Clin Oncol, 2010; June 21 Epub ahead of print.
  • American Academy of Pediatrics Committee on Bioethics. Ethical Issues with Genetic Testing in Pediatrics. Pediatrics, 2001; 107:1451–1455.
  • ASHG/ACMG Report. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Amer J Human Genet 1995; 57:1233–1241.
  • Plumridge G, Metcalfe A, Coad J, Gill P. Family communication about genetic risk information: particular issues for Duchenne muscular dystrophy. Am J Med Genet 2010; 152A:1225–1232.
  • Szybowska M, Hewson S, Antle BJ, Babul-Hirji R. Assessing the informational needs of adolescents with a genetic condition; what do they want to know? J Genet Counsel 2006; DOI:10.1007/s10897–006-9060–5
  • Twomey JG. Issues in genetic testing of children. Am J Mat Child Nurs 2006; 31(3):156–163.
  • Rhodes R. Why test children for adult-onset genetic diseases? (2006). Mt Sinai J Med 2006; 73(3):609–616.
  • Duncan RE, Delatycki MB. Predicitive genetic testing in young people for adult-onset conditions: where is the empirical evidence? Clin Genet 2006; 69:8–16.
  • Duncan RE, Savulescu J, Gillam L, Williamson R, Delatycki MB. An international survey of predictive genetic testing in children for adult onset conditions. Gen Med 2005; 7(6):390–396.
  • Bernhardt BA, Tambor ES, Fraser G, Wissow LS, Geller G. Parent's and children's attitudes toward the enrollment of minors in genetic susceptibility. Amer J Med Genet 2003; 116A:315–323.
  • American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Amer J Respir Crit Care Med 2003; 168:818–900.
  • Kopelman LM. Using the best interests standard to decide whether to test children for untreatable, late-onset genetic diseases. J Med Philos 2007; 32:375–394.
  • Pelias MK. Genetic testing of children for adult-onset diseases: is testing in the child's best interests? Mt Sinai J Med 2006; 73(3):605–608.
  • Carpenter MJ, Strange C, Jones Y, Dickson MR, Carter C, Moseley MA, Gilbert GE. Does genetic testing result in behavior health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med 2007; 33(1):22–28.
  • Strange C, Dickson R, Carter C, Carpenter M, Holladay B, Lundquist R, Brantly ML. Genetic testing for alpha-1antitrypsin deficiency. Genet Med 2004; 6(4):204–210.
  • Buist AS. Alpha 1 Antitrypsin deficiency: diagnosis, treatment and control: identification of patients. Lung 1990; 168(suppl):543–551.
  • Mayer AS, Stoller JK, Bucher Bartelson B, James Ruttenber A, Sandhaus RA, Newman LS. Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med 2000; 162:553–558.
  • Silverman EK, Province MA, Campbell EJ, Pierce JA, Rao DC. Family study of alpha1 -antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits. Genet Epidem 1992; 9:317–31.
  • World Health Organization. Alpha-1 antitrypsin deficiency: memorandum from a WHO meeting. Bull WHO 1997; 75:397–416.
  • Wilfond B, Ross LF. From genetics to genomics: ethics, policy, and parental decision-making. J Pediatr Psychol 2009; 34:639–647.
  • Sveger T, Thelin T. A future for neonatal alpha-1 antitrypsin screening? Acta Paediat Scandin 2000; 89: 259–261.
  • Bonn D. Genetic testing and insurance: fears unfounded? Lancet 2000; 355(9214):1526–1527.
  • Moseley R. Ethical issues in genetic testing for insurance. J Insur Med, 1993; 5(2):255–258.
  • Moseley R, Crandall L, Ostrer H, Allen B, McCrary M, Dewar M. The Ethical, legal and social implications of predictive genetic testing for health, life and disability insurance: policy analysis and recommendations, University of Florida, 1995.
  • Klitzman R. The impact of social contexts in testing for alpha-1 antitrypsin deficiency: the roles of physicians and others. Genet Test Mol Biomarkers 2009; 13:269–276.
  • Juengst E. Genetic testing and the moral dynamics of family life. Public Understand Sci 1999; 8:193–205.
  • Thelin T, McNeil TF, Aspegren-Jansson E, Sveger T. Psychological consequences of neonatal screening for alpha 1 antitrypsin deficiency (ATD): Parental attitudes toward “ATD-check-ups” and parental recommendations regarding future screening. Acta Paediat Scandin 1985A; 74:841–847.
  • Thelin T, McNeil TF, Aspegren-Jansson E, Sveger T. Identifying children at high somatic risk: parents’ long-term emotional adjustment to their children's alpha 1 antitrypsin deficiency. Acta Psychiat Scandin 1985B; 72:323–330.
  • Thelin T, McNeil TF, Aspegren-Jansson E, Sveger T. Psychological consequences of neonatal screening for alpha-1 antiprypsin deficiency, parental reactions to the first news of their infants’ deficiency. Acta Paediat Scandin 1985C; 74:787–793.
  • Fanos JH. Developmental tasks of childhood and adolescence: implications for genetic testing. Am J Med Genet 1997; 71(1):22–28.
  • Campbell E, Ross LF. Professional and personal attitudes about access and confidentiality in the genetic testing of children: a pilot study. Genet Test 2003; 7(2):123–130.
  • Robertson S, Savulescu J. Is there a case in favor of predictive genetic testing in young children? Bioethics 2001; 15:26.
  • Penson PT, Sieden MV, Shannon KM, Lubratovich ML, Roche M, Chabner BA, Lynch TJ. Communicating genetic risk: pros, cons, and counsel. Oncologist 2000; 5:152–161.
  • Moseley R, Crandall L, Osterer H, Allen B, McCrary M, Dewan M. The ethical legal and social implications of preductive genetic Testing for Health, Life and Disability Insurance: Policy Analysis and Recommendations. Gainesville, FL: University of Florida Press, 1995.
  • Coon DW, Davies H, McKibben C, Gallagher-Thompson D. The psychological impact of genetic testing for Alzheimer disease. Genet Test 1999; 3:121–131.
  • Wade CH, Wilfond BS, McBride CM. Effects of genetic risk information on children's psychosocial wellbeing: a systematic review of the literature. Genet Med 2010; 12:317–326.
  • McConkie-Rosell A, Spiridigliozzi GA, Melvin E, Dawson DV, Lachiewicz AM. Living with genetic risk: effect on adolescent self-concept. Am J Med Genet C Semin Med Genet 2008; 148C: 56–69.
  • Malpas PJ. Predictive genetic testing of children for adult-onset diseases and psychological harm. J Med Ethics 2008; 34:275–278.
  • Borry P, Stultiens L, Nys H, Dierickx K. Attitudes towards predictive genetic testing in minors for familial breast cancer: a systematic review. Crit Rev Onc/Hematol 2008; 64:173–181.
  • Coors ME. A Foucauldian foray into the new genetics. J Med Human 2003; 24(3/4):279–289.
  • Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB. “Your're one of us now”: young people describe their experiences of predictive genetic testing for Huntinton disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet 2008; 148C:47–55.
  • Coors ME. Genes in families: attitudes toward genetic testing for schizophrenia. Schizophren Res 2005; 72:271–273.
  • Fanos JH, Strange C. The lion, the witch and the wardrobe: impact on sibs of individuals with AAT deficiency. Am J Med Genet 2004; 130A:251–257.
  • Dillman DA. Mail and Internet Surveys: The Tailored Design Method. New York: John Wiley & Sons, Inc, 2000.
  • Dhondt JL. Expanded newborn screening: social and ethical issues. J Inherit Metab Dis, 2010; June 11:Epub ahead of print.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.